• 1 •Chin J Integr Med Depressive symptoms do not represent a mood disorder, but rather an organic dysfunction.(1) Depressive symptoms and cognitive decline are common in schizophrenia, major depressive disorder (MDD), bipolar disorder, and Alzheimer's disease (AD).(2) Moreover, depressive symptoms have been associated with increased risk of cognitive decline.(1) The relationship between depressive symptoms and cognitive decline is complex. Recently, cross-sectional studies have demonstrated a strong association between progression of depressive symptoms and white-matter changes, particularly in frontal pathology.(3) Neuroimaging and postmortem studies have also linked the depressive and cognitive symptoms of these disorders …show more content…
Two concentrations of induced demyelination was used to mimic demyelinating disease. Two concentrations of A. . catechucatechu nut extract nut extract (ANE; 1% and 2%) were administered orally in the diet for 8 weeks. Depressive symptoms and cognition-associated (ANE; 1% and 2%) were administered orally in the diet for 8 weeks. Depressive symptoms and cognition-associated behaviors were evaluated in tests of locomotor activity, tail suspension, and forced swimming; spatial memory was behaviors were evaluated in tests of locomotor activity, tail suspension, and forced swimming; spatial memory was tested with the Y-maze. Expression of myelin basic protein (MBP), 2',3'-cyclic-nucleotide 3'-phosphodiesterase tested with the Y-maze. Expression of myelin basic protein (MBP), 2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNPase), glutathione S-transferases pi (GSTpi), brain-derived neurotrophic factor (BDNF), and the transcription (CNPase), glutathione S-transferases pi (GSTpi), brain-derived neurotrophic factor (BDNF), and the transcription factor cyclic adenosine monophosphate (cAMP) response element-binding (CREB) were evaluated by western blot. factor cyclic adenosine monophosphate (cAMP) response element-binding (CREB) were evaluated by western blot. ResultsResults: Animals subjected to demyelination showed hyperactivity (: Animals subjected to demyelination showed hyperactivity (P<0.01), impaired spatial memory (<0.01), impaired spatial memory (P<0.01),
Animals with a bigger cage and more toys did not perform any different than the control group
Regional GMV was decreased significantly in the lateral and medial temporal regions (including hippocampi) in the MCI group compared with the control group (Supplementary Figure S1 and Supplementary Table S3). In contrast to GMV, no significant differences were observed between groups in
In order to ensure that this experiment will give us an outcome, we can compare it to a study that has already been conducted. Siberian hamsters were
Improves memory and learning and provides neuroprotection in models of ALS and PD, in CNS and PNS in jury and in neuropathy and retinal degeneration
One of the main symptoms of the patients affected by AGC1 deficiency, i.e. the cerebral atrophy with global brain hypomyelination suggests that the blocked efflux of aspartate from neuronal mitochondria, due to the impaired AGC1, can alter the normal myelin formation (Falk et al., 2014; Wibom et al., 2009; Wolf & van der Knaap, 2009). The cytosolic aspartate is essential for many synthetic processes as that of urea, purines, pyrimidines and proteins. In neurons, aspartate and acetylCoA are the reagents of the Aspartate N-acetyl transferase (ANAT) enzyme that produces NAA (Goldstein, 1959; Knizley, 1967; Truckenmiller, Namboodiri, Brownstein, & Neale, 1985). NAA is the more concentrated molecule in
Sahar Salimi-Mosavi, Human Biology Program, University of Toronto, Dr. Lili-Naz Hazrati, Department of Laboratory of Medicine and Pathology, Tanz Centre for Research in Neurodegenerative Diseases
A water maze was used to assess spatial memory for the location of an escape platform, followed by a test of reversal learning, after the platform is moved to an alternate quadrant in the maze. For the rats both males and females, 2 groups of prepubertal animals were tested, both females and males along with a group of newly postpubertal animals and a group of young adults. After the platform location changed, individual prepubertal males and
Development of treatments for brain disorders has always been a problematic issue due to the lack of knowledge and information on the physiology and mechanisms of many of these disorders (Stoeckel, 2014, p. 245). Various diseases, especially the lethal ones such as Parkinson’s and Alzheimer’s disease, have many unanswered questions and vast gaps to be filled at the biological level that are critical in formulating treatments for each disease (Stoeckel, 2014, p. 246). As a result, the development of novel, safe and effective treatments is very slow, and much more research is required to uncover the physiological underpinnings of these diseases.
The human brain is a complex structure that gives an individual the cognitive ability to perform a variety of actions. The cerebellum, hypothalamus, hippocampus and Wernicke’s area of the brain work together to help coordinate different impulses and actions. A regular activity- such as bathing my daughter would become severely hampered if damage were to occur in these areas of the brain.
Nicotinamide is inhibitor of poly(ADP-ribose) polymerase (PARP-1) enzymes. Poly(ADP-ribose) polymerase-1 (PARP-1) is found as a DNA repair enzyme. The excessive activation of PARP-1, such as ischemia and trauma, can deplete cellular nicotinamide adenine dinucleotide as a substrate and leads to brain cell death eventually.
This case study involved question of whether certain experiences produce physical changes in the brain. It all started back in 1785 when Vincenzo Malacarne, an Italian anatomist studied pairs of dogs from the same litter and pairs of birds from the same batches of eggs. He would train one participant extensively over a long period time while the other would be equally cared for but not trained. He discovered in autopsies of the animals that the brains of the one that he trained appeared more complex and with a greater number of folds and fissures on the brain. This research for unknown reasons was discontinued.
When they are activated that mediates Ca2+ entry. It has become gradually clear that detrimental effects can arise from either hyperactivity or hypofunction of NMDARs. Moreover, NMDARs dysfunction has emerged as a common theme in several major nervous system disorders, including ischemic brain injury, chronic neurodegenerative diseases, pain, depression and schizophrenia, altered NMDARs presence/functions can be contributed in central nervous system (CNS) disease in several ways
We will further discuss the pre-clinical and clinical studies testing the potential in which the modulation of these factors could be used for therapeutic applications in neurodegeneration.
A. The mammalian brain is composed of billions of neurons and trillions of synaptic connections. Synapses are specialized connections, which mediate the information flow through a presynaptic neuron to a postsynaptic target neuron. Proteins localized at the synapse described as the synaptic proteome, are key mediators of learning, memory, sensory integration, and emotional responses. The functional loss or dysregulation of various synaptic proteins is associated with neurodegenerative diseases. The composition of proteins at the synapse is regulated by (1) active transport of proteins from the cell body and (2) synthesis of proteins by translation at the synapse and (3) local protein degradation. Transport of proteins and RNAs to synapses
Pro-inflammatory changes lead to significant impairment in cognitive function in mouse models of AD {Heneka, 2002 #28}, {Heneka, 2006 #30}, {Jardanhazi-Kurutz, 2010 #38}, {Kalinin, 2007 #39} {Pugh, 2007 #69}. In addition, DSP4-mediated destruction of NE-ergic cells leads to decreased migration and phagocytosis by microglia and reduced colocalization between microglia and Aβ {Heneka, 2010 #29}. This suggests that a loss of NE-ergic cells could result in lower microglial cell function and a decrease in Aβ clearance in patients with AD. Indeed, DSP-4 injections in the Ts65Dn mouse model of DS has resulted in increased hippocampal inflammation and accelerated degeneration into AD-like pathology {Lockrow, 2011 #54}.